|1.||Gomis, R: 3 articles (03/2011 - 05/2009)|
|2.||Ozturk, Nihal: 2 articles (01/2014 - 08/2012)|
|3.||Ozdemir, Semir: 2 articles (01/2014 - 08/2012)|
|4.||Gomis, Ramon: 2 articles (01/2012 - 02/2009)|
|5.||Carmona, M C: 2 articles (03/2011 - 05/2009)|
|6.||Barceló-Batllori, S: 2 articles (03/2011 - 05/2009)|
|7.||Donmez, Baris O: 1 article (01/2014)|
|8.||Oguz, Nurettin: 1 article (01/2014)|
|9.||Sarikanat, Mehmet: 1 article (01/2014)|
|10.||Sari, Ramazan: 1 article (01/2014)|
11/01/2010 - "Proof-of-concept trial on the efficacy of sodium tungstate in human obesity."
02/03/2012 - "Anti-diabetic and anti-obesity agent sodium tungstate enhances GCN pathway activation through Glc7p inhibition."
01/01/2012 - "Anti-obesity sodium tungstate treatment triggers axonal and glial plasticity in hypothalamic feeding centers."
03/01/2011 - "Sodium tungstate is an anti-obesity drug targeting peripheral tissues. "
11/01/2010 - "Our data do not support sodium tungstate as a pharmacological agent in the treatment of human obesity."
|2.||Body Weight (Weight, Body)
03/01/2011 - "In vivo, sodium tungstate reduces body weight gain and food intake through increasing energy expenditure and lipid oxidation, but it also modulates hypothalamic gene expression when orally administered, raising the possibility of a direct effect of sodium tungstate on the central nervous system. "
08/01/2010 - "Diabetes was induced with an intraperitoneal STZ injection (65 mg/kg body weight), and sodium tungstate with concentration of 2 g/L was added to drinking water of treated animals for 4 weeks. "
01/01/2014 - "Sodium tungstate achieved a little (17%) but significant reduction on blood glucose levels, while it didn't recover the reduced body weights of diabetic rats. "
01/01/2012 - "Sodium tungstate treatment reduced body weight gain, food intake, and blood glucose and triglyceride levels. "
03/01/2011 - "Sodium tungstate regulates food intake and body weight through activation of the hypothalamic leptin pathway."
08/01/2012 - "This beneficial effect is due to antioxidant property of sodium tungstate rather than normalization of hyperglycemia."
08/01/2012 - "Sodium tungstate administration ameliorated diabetes-induced electrical and contractile remodeling of rat heart without normalization of hyperglycemia."
08/01/2010 - "Sodium tungstate reduced the hyperglycemia and restored the diabetes-induced changes in all mentioned markers of oxidative stress. "
01/01/2012 - "Oral administration of sodium tungstate has shown hyperglycemia-reducing activity in several animal models of diabetes. "
08/01/2000 - "Sodium tungstate has been found to correct hyperglycemia in insulin- and noninsulin-dependent models of diabetes when administered in drinking fluid with a low degree of toxicity; thus, it provides a potential treatment for diabetes. "
|5.||Weight Loss (Weight Reduction)
|1.||Blood Glucose (Blood Sugar)
|3.||Sodium Selenite (Selenite)
|4.||Proteins (Proteins, Gene)
|7.||sodium chromate(VI) (sodium chromate)
|8.||tellurous acid (tellurate)